Shandong Wohua Pharmaceutical Co., Ltd.
Símbolo: 002107.SZ
SHZ
4.82
CNYPrecio de mercado actual
64.7237
Ratio PER
-0.2255
Ratio PEG
2.78B
Capitalización MRK
- 0.00%
Rendimiento DIV
Shandong Wohua Pharmaceutical Co., Ltd. (002107-SZ) Estados Financieros
Balance de situación
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 1553.9 | 401.1 | 278.3 | 326.8 | |||||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.net-receivables | 489.91 | 120.5 | 165.9 | 120.6 | |||||||||||||||||||||
balance-sheet.row.inventory | 580.07 | 149.1 | 146 | 165.9 | |||||||||||||||||||||
balance-sheet.row.other-current-assets | 31.94 | 2.3 | 9 | 7.2 | |||||||||||||||||||||
balance-sheet.row.total-current-assets | 2655.83 | 673 | 599.2 | 620.6 | |||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 1542.42 | 383.2 | 409.8 | 447.7 | |||||||||||||||||||||
balance-sheet.row.goodwill | 130.03 | 32.5 | 32.5 | 32.5 | |||||||||||||||||||||
balance-sheet.row.intangible-assets | 144.07 | 36.8 | 36 | 54.8 | |||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 274.1 | 69.4 | 68.5 | 87.3 | |||||||||||||||||||||
balance-sheet.row.long-term-investments | 73.91 | 18.4 | 19.1 | 0 | |||||||||||||||||||||
balance-sheet.row.tax-assets | 2.8 | 0.7 | 1.2 | 2.8 | |||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 6.43 | 0 | 2.2 | 2.7 | |||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 1899.66 | 471.7 | 500.8 | 540.5 | |||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.total-assets | 4555.49 | 1144.7 | 1100 | 1161.1 | |||||||||||||||||||||
balance-sheet.row.account-payables | 223.67 | 52.9 | 45.3 | 26.8 | |||||||||||||||||||||
balance-sheet.row.short-term-debt | 4.7 | 2.7 | 1 | 2.8 | |||||||||||||||||||||
balance-sheet.row.tax-payables | 39.43 | 3.1 | 31.3 | 20.9 | |||||||||||||||||||||
balance-sheet.row.long-term-debt-total | -17.39 | -17.9 | 0.4 | 0.1 | |||||||||||||||||||||
Deferred Revenue Non Current | 72.77 | 17.9 | 20.7 | 23.8 | |||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 17.38 | - | - | - | |||||||||||||||||||||
balance-sheet.row.other-current-liab | 762.54 | 226.7 | 224.7 | 168.5 | |||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 75.16 | 5.3 | 26.8 | 28.1 | |||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 1.01 | 0.4 | 0.4 | 0 | |||||||||||||||||||||
balance-sheet.row.total-liab | 1209.2 | 293.3 | 310.2 | 231.8 | |||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.common-stock | 2308.84 | 577.2 | 577.2 | 577.2 | |||||||||||||||||||||
balance-sheet.row.retained-earnings | 731.37 | 183.8 | 129.7 | 183.7 | |||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 167.6 | 44.2 | 39.6 | 59.8 | |||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 3207.81 | 805.3 | 746.5 | 820.7 | |||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 4555.49 | 1144.7 | 1100 | 1161.1 | |||||||||||||||||||||
balance-sheet.row.minority-interest | 120.56 | 28.2 | 43.3 | 108.5 | |||||||||||||||||||||
balance-sheet.row.total-equity | 3328.36 | 833.5 | 789.8 | 929.3 | |||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 4555.49 | - | - | - | |||||||||||||||||||||
Total Investments | 73.91 | 18.4 | 19.1 | 0 | |||||||||||||||||||||
balance-sheet.row.total-debt | 4.74 | 2.7 | 1.4 | 2.8 | |||||||||||||||||||||
balance-sheet.row.net-debt | -1549.16 | -398.4 | -276.9 | -324 |
Estado de tesorería
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 42.99 | 58.8 | 89.9 | 161.3 | |||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | -0.12 | 33.2 | 35.3 | 33 | |||||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0.7 | 2.2 | 1.3 | |||||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | -18.9 | -2.2 | -1.3 | |||||||||||||||||||||
cash-flows.row.change-in-working-capital | 44.96 | 47.6 | 54.9 | -14 | |||||||||||||||||||||
cash-flows.row.account-receivables | 50.32 | 50.3 | -40.8 | 63.3 | |||||||||||||||||||||
cash-flows.row.inventory | -5.36 | -5.4 | 15.5 | -53.8 | |||||||||||||||||||||
cash-flows.row.account-payables | 0 | 2.6 | 78.1 | -24.8 | |||||||||||||||||||||
cash-flows.row.other-working-capital | 0 | 0 | 2.2 | 1.3 | |||||||||||||||||||||
cash-flows.row.other-non-cash-items | 64.7 | 7.8 | 5.1 | 19.8 | |||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 152.53 | 0 | 0 | 0 | |||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -2.21 | -2.7 | -6.8 | -19.1 | |||||||||||||||||||||
cash-flows.row.acquisitions-net | 0.06 | 0.1 | 1.2 | 0 | |||||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | |||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | |||||||||||||||||||||
cash-flows.row.other-investing-activites | 0.06 | 0 | 0 | 0 | |||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -2.15 | -2.6 | -5.6 | -19.1 | |||||||||||||||||||||
cash-flows.row.debt-repayment | 0 | 0 | -0.3 | -188.8 | |||||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | -150.1 | -154.9 | |||||||||||||||||||||
cash-flows.row.other-financing-activites | -3.55 | -3.6 | -79 | -188.8 | |||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -3.55 | -3.6 | -229.3 | -343.7 | |||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | -0.14 | -0.3 | 0 | 0 | |||||||||||||||||||||
cash-flows.row.net-change-in-cash | 147.9 | 122.8 | -49.7 | -162.6 | |||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 1551.56 | 401.1 | 276.5 | 326.2 | |||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 1403.67 | 278.3 | 326.2 | 488.9 | |||||||||||||||||||||
cash-flows.row.operating-cash-flow | 152.53 | 129.2 | 185.3 | 200.1 | |||||||||||||||||||||
cash-flows.row.capital-expenditure | -2.21 | -2.7 | -6.8 | -19.1 | |||||||||||||||||||||
cash-flows.row.free-cash-flow | 150.32 | 126.5 | 178.5 | 181 |
Fila de la Cuenta de Resultados
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 882.86 | 894.3 | 1014.8 | 942.7 | |||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 235.14 | 241.4 | 250.9 | 212.4 | |||||||||||||||||||||
income-statement-row.row.gross-profit | 647.73 | 652.9 | 763.9 | 730.3 | |||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||||
income-statement-row.row.research-development | 37.89 | - | - | - | |||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 19.49 | - | - | - | |||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 491.95 | - | - | - | |||||||||||||||||||||
income-statement-row.row.other-expenses | 0.2 | -2.3 | 63 | 41.9 | |||||||||||||||||||||
income-statement-row.row.operating-expenses | 613.64 | 606.5 | 651.5 | 523.4 | |||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 848.78 | 848 | 902.4 | 735.7 | |||||||||||||||||||||
income-statement-row.row.interest-income | 4.85 | 5.2 | 4.7 | 6.8 | |||||||||||||||||||||
income-statement-row.row.interest-expense | 0.03 | 0 | 0 | 4.7 | |||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 491.95 | - | - | - | |||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 5.22 | 8.3 | -1.5 | -2.7 | |||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0.2 | -2.3 | 63 | 41.9 | |||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 5.22 | 8.3 | -1.5 | -2.7 | |||||||||||||||||||||
income-statement-row.row.interest-expense | 0.03 | 0 | 0 | 4.7 | |||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 18.56 | 33.2 | 38.5 | 50.1 | |||||||||||||||||||||
income-statement-row.row.ebitda-caps | 48.25 | - | - | - | |||||||||||||||||||||
income-statement-row.row.operating-income | 34.94 | 46.3 | 112.3 | 192.7 | |||||||||||||||||||||
income-statement-row.row.income-before-tax | 40.17 | 54.6 | 110.8 | 190 | |||||||||||||||||||||
income-statement-row.row.income-tax-expense | 7.01 | 8 | 20.9 | 28.6 | |||||||||||||||||||||
income-statement-row.row.net-income | 42.99 | 58.8 | 107.4 | 163.4 |
Preguntas frecuentes
Cuánto es Shandong Wohua Pharmaceutical Co., Ltd. (002107.SZ) activos totales?
Shandong Wohua Pharmaceutical Co., Ltd. (002107.SZ) los activos totales son 1144706388.000.
¿Cuáles son los ingresos anuales de la empresa?
Los ingresos anuales son 401753358.000.
¿Cuál es el margen de beneficios de la empresa?
El margen de beneficios de la empresa es 0.734.
¿Qué es el flujo de caja libre de la empresa?
El flujo de caja libre es 0.260.
¿Cuál es el margen de beneficio neto de la empresa?
El margen de beneficio neto es 0.049.
¿Cuáles son los ingresos totales de la empresa?
Los ingresos totales son 0.040.
¿Qué es Shandong Wohua Pharmaceutical Co., Ltd. (002107.SZ) beneficio neto (ingresos netos)?
El beneficio neto (ingresos netos) es 58767086.000.
¿Cuál es la deuda total de la empresa?
La deuda total es 2727141.000.
¿Cuál es la cifra de gastos de explotación?
Los gastos de explotación son 606549582.000.
¿Cuál es la cifra de tesorería de la empresa?
La tesorería de la empresa es 456686925.000.